
In a target trial emulation using N3C data, adults prescribed metformin within six days of SARS-CoV-2 infection had about half the risk of long COVID or death within six months.
MediFind's Patrick Howie examines the consolidation of resources during pandemics amid concerns that funding will not return to other areas of health research.
MediFind CEO Patrick Howie examines the consolidation of funding around certain infectious disease threats during pandemics amid concerns that funding will not return to other areas of health research.






